News & Updates

Treatment with mevrometostat (MEV), an enhancer of zeste homolog 2 inhibitor, in combination with enzalutamide (ENZ) results in better survival outcomes and response than ENZ alone among patients with metastatic castration-resistant prostate cancer (mCRPC), reports a study presented at ASCO GU 2025. The combined therapy also demonstrates a favourable safety profile.

A novel sensing device shows potential for detecting lung cancer before symptoms appear.

Knowledge levels about COVID-19 are high among kidney transplant recipients and low among donors, particularly those who are older, with lower education, and patients with financial concerns or feelings of social isolation, according to a Singapore study.

Augmenting standard physical therapy (PT) with a progressively higher-intensity walking exercise programme in inpatient stroke rehabilitation units improved mobility and quality of life (QoL) in stroke survivors, a study has shown.